Literature DB >> 30840093

Incident depression and mortality among people with different types of dementia: results from a longitudinal cohort study.

Laura Perna1, H W Wahl2,3, J Weberpals4, L Jansen4, U Mons4,5, B Schöttker4,3, H Brenner4,3.   

Abstract

PURPOSE: The aim of this study was to investigate the independent and combined association of incident depression and dementia with mortality and to explore whether the magnitude of the association varies according to different types of dementia, including Alzheimer's disease and vascular dementia. METHODS AND
DESIGN: The study was based on a population-based longitudinal cohort consisting of 9940 participants at baseline and followed for over 14 years. The sample used for the analyses included 6114 participants with available information on diagnosis of incident dementia and depression. For survival analyses, Cox regression models with incident dementia (n = 293; 5%) and incident depression (n = 746; 12%) as time-dependent variables were used.
RESULTS: Cox models adjusted for relevant confounders indicated that comorbidity of incident vascular dementia and incident depression was associated with a much higher mortality risk (HR 6.99; 95% CI 3.84-12.75) than vascular dementia in the absence of depression (HR 2.80; 95% CI 1.92-4.08). In contrast, estimates for comorbidity of Alzheimer's disease and depression were slightly lower than those for Alzheimer in absence of depression (HR 3.56; 95% CI 1.83-6.92 and HR 4.19; 95% CI 2.97-5.90, respectively). Incident depression in the absence of incident dementia was only weakly associated with mortality.
CONCLUSIONS: These findings indicate that depression and vascular dementia might have synergistic effects on mortality. The results have relevant public health implications for prevention, routine screening for and early treatment of depression among older people, especially those at risk of vascular dementia.

Entities:  

Keywords:  Alzheimer’s disease; Dementia; Depression; Mortality

Mesh:

Year:  2019        PMID: 30840093     DOI: 10.1007/s00127-019-01683-0

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  28 in total

1.  The association of depression and mortality in elderly persons: a case for multiple, independent pathways.

Authors:  D G Blazer; C F Hybels; C F Pieper
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-08       Impact factor: 6.053

2.  Depression in vascular dementia is quantitatively and qualitatively different from depression in Alzheimer's disease.

Authors:  J H Park; S B Lee; T J Lee; D Y Lee; J H Jhoo; J C Youn; I H Choo; E A Choi; J W Jeong; J Y Choe; J I Woo; K W Kim
Journal:  Dement Geriatr Cogn Disord       Date:  2006-11-15       Impact factor: 2.959

3.  Illustrating bias due to conditioning on a collider.

Authors:  Stephen R Cole; Robert W Platt; Enrique F Schisterman; Haitao Chu; Daniel Westreich; David Richardson; Charles Poole
Journal:  Int J Epidemiol       Date:  2009-11-19       Impact factor: 7.196

4.  Excess mortality in depression: a meta-analysis of community studies.

Authors:  Pim Cuijpers; Filip Smit
Journal:  J Affect Disord       Date:  2002-12       Impact factor: 4.839

Review 5.  Depression in Alzheimer's disease and other dementias.

Authors:  R J Boland
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

6.  [Epidemiological investigations of the chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population (ESTHER study)].

Authors:  M Löw; C Stegmaier; H Ziegler; D Rothenbacher; H Brenner
Journal:  Dtsch Med Wochenschr       Date:  2004-12-03       Impact factor: 0.628

7.  Helicobacter pylori infection and chronic atrophic gastritis: associations according to severity of disease.

Authors:  Melanie N Weck; Lei Gao; Hermann Brenner
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

Review 8.  Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.

Authors:  Carl Salzman; Dilip V Jeste; Roger E Meyer; Jiska Cohen-Mansfield; Jeffrey Cummings; George T Grossberg; Lissy Jarvik; Helena C Kraemer; Barry D Lebowitz; Katie Maslow; Bruce G Pollock; Murray Raskind; Susan K Schultz; Philip Wang; Julie M Zito; George S Zubenko
Journal:  J Clin Psychiatry       Date:  2008-06       Impact factor: 4.384

Review 9.  Diagnosis and treatment of older adults with depression in primary care.

Authors:  Jürgen Unützer
Journal:  Biol Psychiatry       Date:  2002-08-01       Impact factor: 13.382

10.  Validity of a self-reported diagnosis of depression among participants in a cohort study using the Structured Clinical Interview for DSM-IV (SCID-I).

Authors:  Almudena Sanchez-Villegas; Javier Schlatter; Felipe Ortuno; Francisca Lahortiga; Jorge Pla; Silvia Benito; Miguel A Martinez-Gonzalez
Journal:  BMC Psychiatry       Date:  2008-06-17       Impact factor: 3.630

View more
  3 in total

1.  Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer's disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies.

Authors:  Thi Ngoc Mai Nguyen; Li-Ju Chen; Kira Trares; Hannah Stocker; Bernd Holleczek; Konrad Beyreuther; Hermann Brenner; Ben Schöttker
Journal:  Alzheimers Res Ther       Date:  2022-05-28       Impact factor: 8.823

2.  Depression as a Risk Factor for Dementia and Alzheimer's Disease.

Authors:  Vanesa Cantón-Habas; Manuel Rich-Ruiz; Manuel Romero-Saldaña; Maria Del Pilar Carrera-González
Journal:  Biomedicines       Date:  2020-10-28

3.  Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years.

Authors:  H Stocker; L Perna; K Weigl; T Möllers; B Schöttker; H Thomsen; B Holleczek; D Rujescu; H Brenner
Journal:  Mol Psychiatry       Date:  2020-05-13       Impact factor: 15.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.